This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany



YiPSCELL is a biotech company that uses induced pluripotent stem cells to produce normal and diseased cell lines, provide platform services for disease modeling, and develop stem cell-based therapeutics.

“Seek for the sick”We are committed to research, development, and application processes to diagnose and treat patients with incurable diseases that cannot be resolved with modern medicine.

“From Therapy to Recovery”We have established a strategy to focus on induced pluripotent stem cells among various stem cells. Induced pluripotent stem cells have great potential because it is easy to acquired cells and has a wide range of differentiation capabilities. We will develop stem cell therapies that aim regeneration and functional recovery of ageing organs so as to provide promising treatments in this era of ultra-aging society.